Novo Nordisk A/S ADR buy Sanford C. Bernstein
Start price
09.09.25
/
50%
€45.85
Target price
09.09.26
-
Performance (%)
-28.79%
Price
22:25
€32.65
Summary
This prediction is currently active. The price of Novo Nordisk A/S ADR has decreased since the start of the prediction. Compared to the start price this results in a performance of -28.79%. This prediction currently runs until 09.09.26. The prediction end date can be changed by Sanford_C__Bernstein at any time. Sanford_C__Bernstein has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Novo Nordisk A/S ADR | 0.452% | 0.452% |
| iShares Core DAX® | -0,44 % | -5,31 % |
| iShares Nasdaq 100 | -0,19 % | 3,08 % |
| iShares Nikkei 225® | -0,95 % | -5,88 % |
| iShares S&P 500 | -0,42 % | 0,92 % |
Comments by Sanford_C__Bernstein for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE:NVO) was upgraded by analysts at Sanford C. Bernstein from a "market perform" rating to an "outperform" rating.
Ratings data for NVO provided by MarketBeat